Outlook Therapeutics (OTLK) Notes Payables: 2015-2020
Historic Notes Payables for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to $3.6 million.
- Outlook Therapeutics' Notes Payables changed negligibly% to $3.6 million in Q2 2020 from the same period last year, while for Jun 2020 it was $3.6 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $3.6 million for FY2019, which is 21.68% down from last year.
- Outlook Therapeutics' Notes Payables amounted to $3.6 million in Q2 2020, which was down 0.00% from $3.6 million recorded in Q1 2020.
- In the past 5 years, Outlook Therapeutics' Notes Payables ranged from a high of $9.7 million in Q1 2016 and a low of $3.6 million during Q1 2019.
- For the 3-year period, Outlook Therapeutics' Notes Payables averaged around $4.0 million, with its median value being $3.6 million (2020).
- Data for Outlook Therapeutics' Notes Payables shows a maximum YoY plummeted of 71.55% (in 2016) over the last 5 years.
- Outlook Therapeutics' Notes Payables (Quarterly) stood at $4.6 million in 2016, then remained steady at $4.6 million in 2017, then remained steady at $4.6 million in 2018, then decreased by 21.68% to $3.6 million in 2019, then remained steady at $3.6 million in 2020.
- Its Notes Payables stands at $3.6 million for Q2 2020, versus $3.6 million for Q1 2020 and $3.6 million for Q4 2019.